Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
BEFREE |
We used the modified ISTH score for DIC, which is based on platelet count, fibrinogen concentration, and prothrombin time (PT) differences.
|
29065752 |
2019 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
BEFREE |
Abbreviations: AML: acute myeloid leukemia; APL: acute promyelocytic leukemia; WBC: white blood cell; RBC: red blood cell; Hb: hemoglobin; PT: prothrombin time; TT: thrombin time; APTT: activated partial thromboplastin time; TP: total protein; ALB: albumin; AST: aspartate transaminase; ALT: alanine aminotransferase; LDH: lactate dehydrogenase; ATRA: all-trans retinoic acid; ICH: intracranial hemorrhage; DIC: disseminated intravascular coagulation.
|
30453810 |
2019 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
BEFREE |
Prothrombin Complex Concentrate-induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model.
|
31180918 |
2019 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
BEFREE |
Prothrombin time (PT) with international normalized ratio (INR) was estimated at similar intervals to detect venom-induced consumption coagulopathy.
|
30918965 |
2019 |
Disseminated Intravascular Coagulation
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
In Swiss albino mice, intraperitoneal injection of PAF causes sudden death with oxidative stress and disseminated intravascular coagulation (DIC), characterized by prolonged prothrombin time, thrombocytopenia, reduced fibrinogen content, and increased levels of fibrinogen degradation products.
|
31442556 |
2019 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
BEFREE |
Potential factors influencing adverse maternal outcome were male fetus (p = 0.04), postpartum diagnosis of AFLP (p < 0.01), intrauterine fetal death (p = 0.04), disseminated intravascular coagulation (p < 0.01), prothrombin time (p < 0.01) and activated partial thromboplastin time (p = 0.04).
|
29297090 |
2018 |
Disseminated Intravascular Coagulation
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
The disseminated intravascular coagulation (DIC) score, which is based on readily available and relatively inexpensive coagulation parameters, including platelet count, fibrin-related markers, prothrombin time and fibrinogen, has not been reported regarding PVT development in cirrhotic patients to date.
|
29178991 |
2018 |
Disseminated Intravascular Coagulation
|
0.600 |
GeneticVariation
|
disease |
BEFREE |
Secondary outcomes included platelet count, disseminated intravascular coagulation (DIC), and prothrombin time (PT).
|
30064685 |
2018 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
BEFREE |
Laboratory measurement of prothrombin fragment 1.2, a byproduct of prothrombin conversion to thrombin, proved to be a useful way to monitor this patient's DIC over time.
|
30461646 |
2018 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
BEFREE |
Moreover, treatment with rTM significantly improved DIC score, fibrinogen, fibrin/fibrinogen degradation product (FDP), and prothrombin time (PT) ratio.
|
30383650 |
2018 |
Disseminated Intravascular Coagulation
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
From medical records, we collected information about the following coagulation and fibrinolytic factors at hospital admission: platelet count; prothrombin time; activated partial thromboplastin time; plasma levels of fibrinogen, D-dimer, fibrin/fibrinogen degradation products (FDP), and antithrombin; and calculated DIC score.
|
27940211 |
2017 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
BEFREE |
We examined whether a dual short-acting thrombin (factor II) and factor X (FX)a inhibitor (SATI) ameliorates sepsis-induced disseminated intravascular coagulation (DIC) and is organ-protective.
|
28288667 |
2017 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
RGD |
Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model.
|
23737601 |
2013 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
RGD |
Exogenous normal lymph alleviating kidney injury by improving coagulation function in disseminated intravascular coagulation rats.
|
22229668 |
2012 |
Disseminated Intravascular Coagulation
|
0.600 |
AlteredExpression
|
disease |
BEFREE |
DIC, defined as platelet counts below 100 G L(-1), increased D-dimer levels and prolonged prothrombin time, was significantly associated with the 4G4G genotype [31 of 63 (49%) vs. 55 of 175 (31%), P = 0.014], resulting in a hazard ratio (HR) of 1.5 (95% confidence interval 1.1-2.1) to develop DIC.
|
17697137 |
2007 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
BEFREE |
Group 1 and 2 animals developed features of disseminated intravascular coagulation (DIC), with reductions of fibrinogen and platelets and increases of prothrombin time, partial thromboplastin time, and fibrin split products.Graft survival was for 6-13 days.
|
11740383 |
2001 |
Disseminated Intravascular Coagulation
|
0.600 |
Biomarker
|
disease |
CTD_human |
Hirudin in disseminated intravascular coagulation.
|
1894189 |
1991 |